“The role of comorbidities (hypertension, obesity and diabetes) in the expression of the ACE 2 receptor in COVID-19: A systematic review”, RSD, vol. 14, no. 4, p. e0214448590, Apr. 2025, doi: 10.33448/rsd-v14i4.48590.